A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.

We describe a new serine protease inhibition motif in which binding is mediated by a cluster of very short hydrogen bonds (<2.3 A) at the active site. This protease-inhibitor binding paradigm is observed at high resolution in a large set of crystal structures of trypsin, thrombin, and urokinase-type plasminogen activator (uPA) bound with a series of small molecule inhibitors (2-(2-phenol)indoles and 2-(2-phenol)benzimidazoles). In each complex there are eight enzyme-inhibitor or enzyme-water-inhibitor hydrogen bonds at the active site, three of which are very short. These short hydrogen bonds connect a triangle of oxygen atoms comprising O(gamma)(Ser195), a water molecule co-bound in the oxyanion hole (H(2)O(oxy)), and the phenolate oxygen atom of the inhibitor (O6'). Two of the other hydrogen bonds between the inhibitor and active site of the trypsin and uPA complexes become short in the thrombin counterparts, extending the three-centered short hydrogen-bonding array into a tetrahedral array of atoms (three oxygen and one nitrogen) involved in short hydrogen bonds. In the uPA complexes, the extensive hydrogen-bonding interactions at the active site prevent the inhibitor S1 amidine from forming direct hydrogen bonds with Asp189 because the S1 site is deeper in uPA than in trypsin or thrombin. Ionization equilibria at the active site associated with inhibitor binding are probed through determination and comparison of structures over a wide range of pH (3.5 to 11.4) of thrombin complexes and of trypsin complexes in three different crystal forms. The high-pH trypsin-inhibitor structures suggest that His57 is protonated at pH values as high as 9.5. The pH-dependent inhibition of trypsin, thrombin, uPA and factor Xa by 2-(2-phenol)benzimidazole analogs in which the pK(a) of the phenol group is modulated is shown to be consistent with a binding process involving ionization of both the inhibitor and the enzyme. These data further suggest that the pK(a) of His57 of each protease in the unbound state in solution is about the same, approximately 6.8. By comparing inhibition constants (K(i) values), inhibitor solubilities, inhibitor conformational energies and corresponding structures of short and normal hydrogen bond-mediated complexes, we have estimated the contribution of the short hydrogen bond networks to inhibitor affinity ( approximately 1.7 kcal/mol). The structures and K(i) values associated with the short hydrogen-bonding motif are compared with those corresponding to an alternate, Zn(2+)-mediated inhibition motif at the active site. Structural differences among apo-enzymes, enzyme-inhibitor and enzyme-inhibitor-Zn(2+) complexes are discussed in the context of affinity determinants, selectivity development, and structure-based inhibitor design.

[1]  P A Frey,et al.  The Low Barrier Hydrogen Bond in Enzymatic Catalysis* , 1998, The Journal of Biological Chemistry.

[2]  D. Bashford,et al.  Use of 1H NMR spectroscopy and computer simulations To analyze histidine pKa changes in a protein tyrosine phosphatase: experimental and theoretical determination of electrostatic properties in a small protein. , 1997, Biochemistry.

[3]  E. T. Gawlinski,et al.  A reaction-diffusion model of cancer invasion. , 1996, Cancer research.

[4]  J. Haveman,et al.  The relevance of tumour pH to the treatment of malignant disease. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  R. Huber,et al.  Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase. , 1998, Journal of medicinal chemistry.

[6]  V. Bertolasi,et al.  Evidence for resonance-assisted hydrogen bonding. 4. Covalent nature of the strong homonuclear hydrogen bond. Study of the O-H--O system by crystal structure correlation methods , 1994 .

[7]  A. Brunger Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[8]  J. Guthrie Short strong hydrogen bonds: can they explain enzymic catalysis? , 1996, Chemistry & biology.

[9]  S. Remington,et al.  A very short hydrogen bond provides only moderate stabilization of an enzyme-inhibitor complex of citrate synthase. , 1994, Biochemistry.

[10]  Robert M. Stroud,et al.  Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface. , 1995, Biochemistry.

[11]  J. Rebek,et al.  Energetics of a Low Barrier Hydrogen Bond in Nonpolar Solvents , 1996 .

[12]  J. Janc,et al.  A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II). , 2000, Biochemistry.

[13]  Robert M. Stroud,et al.  Design of potent selective zinc-mediated serine protease inhibitors , 1998, Nature.

[14]  H M Holden,et al.  Structures of two thermolysin-inhibitor complexes that differ by a single hydrogen bond. , 1987, Science.

[15]  R K Jain,et al.  Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. , 1994, Cancer research.

[16]  P. Strange,et al.  pH dependence of ligand binding to D2 dopamine receptors. , 1995, Biochemistry.

[17]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[18]  G. K. Ackers,et al.  Kinetics of deoxyhemoglobin subunit dissociation determined by haptoglobin binding: estimation of the equilibrium constant from forward and reverse rates. , 1976, Biochemistry.

[19]  A. Warshel,et al.  Energy considerations show that low-barrier hydrogen bonds do not offer a catalytic advantage over ordinary hydrogen bonds. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Warshel Electrostatic Origin of the Catalytic Power of Enzymes and the Role of Preorganized Active Sites* , 1998, The Journal of Biological Chemistry.

[21]  S L Morrison,et al.  Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. , 1995, Biochemistry.

[22]  W. Lipscomb,et al.  Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography. , 1994, Biochemistry.

[23]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[24]  G. Madsen,et al.  On the electronic nature of low-barrier hydrogen bonds in enzymatic reactions. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Knowles,et al.  Neutral imidazole is the electrophile in the reaction catalyzed by triosephosphate isomerase: structural origins and catalytic implications. , 1991, Biochemistry.

[26]  M. James,et al.  Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues. , 1993, Biochemistry.

[27]  P. Frey,et al.  A low-barrier hydrogen bond in the catalytic triad of serine proteases. , 1994, Science.

[28]  S. Remington,et al.  alpha-Fluoro acid and alpha-fluoro amide analogs of acetyl-CoA as inhibitors of citrate synthase: effect of pKa matching on binding affinity and hydrogen bond length. , 1995, Biochemistry.

[29]  Michael A. McAllister,et al.  Characterization of Low-Barrier Hydrogen Bonds. 6. Cavity Polarity Effects on the Formic Acid−Formate Anion Model System. An ab Initio and DFT Investigation , 1998 .

[30]  B. Katz,et al.  Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator. , 2000, Chemistry & biology.

[31]  W. Bode,et al.  The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. , 1975, Journal of molecular biology.

[32]  John Comer,et al.  pH-Metric log P. 3. Glass electrode calibration in methanol-water, applied to pKa determination of water-insoluble substances , 1993 .

[33]  J. Emsley,et al.  Hydrogen Bonding and Chemical Reactivity , 1991 .

[34]  James Lin,et al.  Derivatives of 5-amidine indole as inhibitors of thrombin catalytic activity , 1996 .

[35]  J. Ladbury Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. , 1996, Chemistry & biology.

[36]  D. Herschlag,et al.  The Energetics of Hydrogen Bonds in Model Systems: Implications for Enzymatic Catalysis , 1996, Science.

[37]  R. Stroud,et al.  Structure and specific binding of trypsin: comparison of inhibited derivatives and a model for substrate binding. , 1974, Journal of molecular biology.

[38]  D. Herschlag,et al.  The change in hydrogen bond strength accompanying charge rearrangement: implications for enzymatic catalysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  W. Cleland,et al.  Low-barrier hydrogen bonds and enzymic catalysis. , 1994, Science.

[40]  K. Takács-Novák,et al.  Interlaboratory study of log P determination by shake-flask and potentiometric methods. , 1996, Journal of pharmaceutical and biomedical analysis.

[41]  E. D. De Fabo,et al.  A low-barrier hydrogen bond in the catalytic triad of serine proteases? Theory versus experiment. , 1997, Science.

[42]  L. Stryer,et al.  pH affects both the mechanism and the specificity of peptide binding to a class II major histocompatibility complex molecule. , 1993, Biochemistry.

[43]  Sung-Hou Kim,et al.  Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa. , 2000, Biochemistry.

[44]  P. Kuzmič,et al.  High-throughput screening of enzyme inhibitors: automatic determination of tight-binding inhibition constants. , 2000, Analytical biochemistry.

[45]  J. P. Malthouse,et al.  A study of the stabilization of tetrahedral adducts by trypsin and delta-chymotrypsin. , 1992, The Biochemical journal.

[46]  C. Perrin,et al.  "Strong" hydrogen bonds in chemistry and biology. , 1997, Annual review of physical chemistry.

[47]  T. Liang,et al.  Complex of alpha-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone: structural studies with NMR spectroscopy. , 1987, Biochemistry.

[48]  R. Day,et al.  A 13C-NMR study of the role of Asn-155 in stabilizing the oxyanion of a subtilisin tetrahedral adduct. , 1997, The Biochemical journal.

[49]  J. H. Shim,et al.  A pH-dependent stabilization of an active site loop observed from low and high pH crystal structures of mutant monomeric glycinamide ribonucleotide transformylase at 1.8 to 1.9 A. , 1998, Journal of molecular biology.

[50]  Michael H. Gelb,et al.  Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. , 1994 .

[51]  R. Stroud,et al.  Structure of an acyl-enzyme intermediate during catalysis: (guanidinobenzoyl)trypsin. , 1990, Biochemistry.

[52]  K. Houk,et al.  Short, Strong Hydrogen Bonds in the Gas Phase and in Solution: Theoretical Exploration of pKa Matching and Environmental Effects on the Strengths of Hydrogen Bonds and Their Potential Roles in Enzymatic Catalysis , 1998 .

[53]  P. Wenthold,et al.  BOND DISSOCIATION ENERGIES OF F2- AND HF2-. A GAS-PHASE EXPERIMENTAL AND G2 THEORETICAL STUDY , 1995 .

[54]  P. Frey,et al.  A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond. , 1997, Biochemistry.

[55]  B. Katz Binding of biotin to streptavidin stabilizes intersubunit salt bridges between Asp61 and His87 at low pH. , 1997, Journal of molecular biology.

[56]  B. Katz,et al.  In Crystals of Complexes of Streptavidin with Peptide Ligands Containing the HPQ Sequence the pK a of the Peptide Histidine Is Less than 3.0* , 1997, The Journal of Biological Chemistry.

[57]  R. Stroud,et al.  Structure of bovine trypsinogen at 1.9 A resolution. , 1977, Biochemistry.

[58]  M. Gilson,et al.  Prediction of pH-dependent properties of proteins. , 1994, Journal of molecular biology.

[59]  P. Schultz,et al.  Linear Free Energy Analysis of Hydrogen Bonding in Proteins , 1995 .

[60]  F. Quiocho,et al.  A low energy short hydrogen bond in very high resolution structures of protein receptor-phosphate complexes , 1997, Nature Structural Biology.

[61]  Michael A. McAllister,et al.  CHARACTERIZATION OF LOW-BARRIER HYDROGEN BONDS. 8. SUBSTITUENT EFFECTS ON THE STRENGTH AND GEOMETRY OF THE FORMIC ACID-FORMATE ANION MODEL SYSTEM. AN AB INITIO AND DFT INVESTIGATION , 1998 .

[62]  L. Gerweck Tumor pH: implications for treatment and novel drug design. , 1998, Seminars in radiation oncology.

[63]  P A Kollman,et al.  On low-barrier hydrogen bonds and enzyme catalysis. , 1995, Science.

[64]  Mary L. Westbrook,et al.  Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. , 1991 .

[65]  R. S. Brown,et al.  Attack of zwitterionic ammonium thiolates on a distorted anilide as a model for the acylation of papain by amides. A simple demonstration of a bell-shaped pH/rate profile , 1992 .

[66]  Beishan Liu,et al.  Structure-Based Design Tools: Structural and Thermodynamic Comparison with Biotin of a Small Molecule That Binds to Streptavidin with Micromolar Affinity , 1996 .

[67]  J. Emsley Very strong hydrogen bonding , 1980 .

[68]  K. Raymond,et al.  The bihydroxide (H3O2-) anion. A very short, symmetric hydrogen bond , 1979 .

[69]  B. Katz,et al.  Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases. , 2000, Journal of molecular biology.